Expand MIRM Menu
MIRM MENU

MIRM Latest Press Releases

-- December 19, 2025 --

Mirum Pharmaceuticals Announces Additional Private Placement Financing With TCGX Business Wire 8:30 AM

-- December 10, 2025 --

Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Business Wire 7:00 PM

-- December 8, 2025 --

Mirum Pharmaceuticals Enters into Definitive Agreement to Acquire Bluejay Therapeutics, Expanding Global Leadership in Rare Disease Business Wire 8:00 AM

-- December 1, 2025 --

Mirum Pharmaceuticals Announces First Patient Enrolled in the BLOOM Phase 2 Clinical Study Evaluating MRM-3379 in Fragile X Syndrome Business Wire 8:10 AM

-- November 25, 2025 --

Mirum Pharmaceuticals to Participate in Upcoming Investor Conferences Business Wire 4:02 PM

-- November 10, 2025 --

Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Business Wire 8:00 PM

-- November 7, 2025 --

Mirum Pharmaceuticals Showcases Leadership in Liver Disease Innovation With Data From LIVMARLI and Volixibat Clinical Programs at AASLD's The Liver Meeting Business Wire 8:10 AM

-- November 4, 2025 --

Mirum Pharmaceuticals Reports Third Quarter 2025 Financial Results and Provides Business Update Business Wire 4:01 PM

-- November 3, 2025 --

Mirum Pharmaceuticals to Participate in Upcoming Investor Conferences Business Wire 4:05 PM

-- October 28, 2025 --

Mirum Pharmaceuticals to Announce Third Quarter 2025 Financial Results and Host Conference Call on November 4, 2025 Business Wire 4:02 PM

-- October 10, 2025 --

Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Business Wire 7:45 PM

-- September 10, 2025 --

Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Business Wire 6:45 PM

-- September 8, 2025 --

Mirum Pharmaceuticals Announces Enrollment Completion in the Phase 2b VISTAS Study Business Wire 8:00 AM

-- August 27, 2025 --

Mirum Pharmaceuticals to Participate in Upcoming Investor Conferences Business Wire 4:02 PM

-- August 6, 2025 --

Mirum Pharmaceuticals Reports Second Quarter 2025 Financial Results and Provides Business Update Business Wire 4:01 PM

-- July 31, 2025 --

Frazier Life Sciences Closes Oversubscribed $1.3 Billion Venture Fund Business Wire 7:00 AM

-- July 30, 2025 --

Mirum Pharmaceuticals to Announce Second Quarter 2025 Financial Results and Host Conference Call on August 6, 2025 Business Wire 4:01 PM
Market Data Delayed 15 Minutes